AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Dec 2, 2016
5262_dirs_2016-12-02_172cde90-6468-4e6a-a0e5-354691fc20ec.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 8685Q
GlaxoSmithKline PLC
02 December 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr S Dingemans
b)
Position/status
Chief Financial Officer
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Acquisition of Ordinary Shares on 1 December 2016 following the exercise of options granted on 30 October 2013 at the option price of £12.47 per Ordinary Share under the Company's ShareSave Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £12.47 | 216 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-12-01
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHELLFBQLFZFBV
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'3OQkpnigYbjdXDO_oyNQzo8jY9GUx-OKgImdKNSgqPeQs22NMiumWXVO2sqMY5hO99RV5G9sMfnUnA4gb9ePgAVxkCPGqXZ1av_YERC50fM1:H4t296o5WAms7CKxnKw38lUBhaPOuuNUIfRc2v4GxfBHpnAhGPbXI-D_sh1PgWozCfbbJUClxvpuUAeIS_JG-9JSCRC23WWBQnN9Pa9rNO41'}});//]]>